
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.030 | 100.030 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.871 | 18.959 |
Price to Book | 3.407 | 2.533 |
Price to Sales | 2.567 | 1.719 |
Price to Cash Flow | 6.098 | 10.489 |
Dividend Yield | 0.155 | 1.017 |
5 Years Earnings Growth | 18.913 | 11.668 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.680 | 15.650 |
Industrials | 18.850 | 21.069 |
Technology | 14.960 | 19.403 |
Financial Services | 10.930 | 13.417 |
Consumer Cyclical | 10.220 | 12.127 |
Energy | 4.790 | 4.738 |
Communication Services | 4.100 | 2.904 |
Consumer Defensive | 3.180 | 3.774 |
Basic Materials | 1.300 | 4.456 |
Number of long holdings: 130
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Crinetics Pharma | US22663K1079 | 2.68 | 31.51 | +3.23% | |
Construction Partners | US21044C1071 | 2.47 | 90.95 | -0.23% | |
Alkami Technology | US01644J1088 | 1.76 | 28.18 | +2.57% | |
Modine Manufacturing | US6078281002 | 1.73 | 91.07 | +0.93% | |
Core Scientific | US21874A1060 | 1.63 | 8.945 | -0.50% | |
OneSpaWorld | BSP736841136 | 1.63 | 18.70 | +2.30% | |
Terawulf | US88080T1043 | 1.54 | 3.032 | -2.83% | |
Rhythm Pharma | US76243J1051 | 1.49 | 65.39 | +4.27% | |
Palomar | US69753M1053 | 1.39 | 156.99 | +0.42% | |
The Vita Coco Co Inc | - | 1.39 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BYZ09Q19 | 2.61B | 32.32 | 4.98 | - | ||
IE00BH4GYB17 | 1.4B | 10.59 | 8.03 | 10.89 | ||
IE00B61H9W66 | 346.07M | 0.72 | 2.74 | 8.49 | ||
IE00B94T1N53 | 346.07M | 0.72 | 2.74 | 8.49 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review